** Shares of Compumedics CMP.AX rise 12.3% to A$0.32, hitting their highest level since Oct. 17
** Medical diagnostics firm expects sales of more than A$55 million ($34.02 million) for fiscal 2025, up from A$52 mln a year ago
** Co also logged sales orders of A$32.8 mln in 1H25 vs A$30.3 mln in 1H24
** Attributes higher sales to U.S. "continuing to provide evidence of accelerating sales growth;" added U.S. orders were up 208% in 1H25 compared to last year
** Stock eyeing its best trading session since early September, if current gains hold
** More than 102,000 shares change hands, 2.4 times the 30-day avg
** Compumedics up 20.8% YTD, including current session's moves
($1 = 1.6166 Australian dollars)
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。